Nutex Health Inc. (NUTX) shareholders
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3069% below fair value
$173.67+2.26 (+1.32%)
Close on Nov 13, 2026Market cap $1.19BP/E 7.4Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
42.9%
3M of 7M shares
Institutional holders
154
38 new, 12 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
5 buys · 1 sales
Net bought $104.74K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Topline Capital Management, LLC Joint filing with Collin McBirney (9.90%), Topline Capital Partners, LP (9.90%) | 556,567 | 9.90% | 13G (passive) amendment | Jul 22, 2025 |
| Pertento Partners LLP Joint filing with Pertento Advisors LLC (5.90%), Eduardo Marques (5.90%) and 1 more | 405,029 | 5.90% | 13G (passive) amendment | May 1, 2026 |
| BlackRock, Inc. | 367,633 | 5.30% | 13G (passive) | Mar 31, 2026 |
| Pertento Advisors LLC Joint filing with Pertento Partners LLP (5.20%), Eduardo Marques (5.20%) | 361,988 | 5.20% | 13G (passive) | Mar 5, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NUTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Pertento Partners LLP | 451,310 | 6.59% | $77.12M | +77,340 | 4.16% |
| BlackRock, Inc. | 407,349 | 5.95% | $69.61M | +27,994 | 0.00% |
| American Century Companies Inc | 237,414 | 3.47% | $40.57M | +33,964 | 0.02% |
| Vanguard Capital Management LLC | 215,919 | 3.15% | $36.90M | −3,212 | 0.00% |
| Geode Capital Management, LLC | 132,049 | 1.93% | $22.57M | +9,936 | 0.00% |
| State Street Corp | 130,836 | 1.91% | $22.36M | +7,659 | 0.00% |
| D. E. Shaw & Co., Inc. | 97,454 | 1.42% | $16.65M | New | 0.01% |
| UBS Group AG | 77,912 | 1.14% | $13.31M | +8,342 | 0.00% |
| Winmill & Co. Inc | 65,350 | 0.95% | $11.17M | – | 2.47% |
| Focus Partners Wealth | 60,881 | 0.89% | $10.40M | New | 0.01% |
| Millennium Management LLC | 52,107 | 0.76% | $8.90M | −37,464 | 0.00% |
| Goldman Sachs Group Inc | 51,244 | 0.75% | $8.76M | +17,449 | 0.00% |
| Bridgeway Capital Management, LLC | 46,924 | 0.69% | $8.02M | +31,904 | 0.14% |
| Empowered Funds, LLC | 45,177 | 0.66% | $7.72M | +12,726 | 0.04% |
| Pacer Advisors, Inc. | 44,614 | 0.65% | $7.62M | +15,938 | 0.02% |
| Northern Trust Corp | 44,056 | 0.64% | $7.53M | +2,789 | 0.00% |
| Topline Capital Management, LLC | 41,764 | 0.61% | $7.14M | −136,036 | 1.85% |
| One Plus One Wealth Management, LLC | 40,441 | 0.59% | $6.91M | – | 2.98% |
| Vanguard Fiduciary Trust Co | 35,969 | 0.53% | $6.15M | +141 | 0.00% |
| Vanguard Portfolio Management LLC | 34,660 | 0.51% | $5.92M | −5,143 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 154 | 3M | 42.9% | 38 / 63 | 35 / 12 | 1M | 0M |
| Q1 2026 | 130 | 3M | 41.0% | 40 / 52 | 26 / 25 | 1M | 1M |
| Q4 2025 | 117 | 3M | 38.3% | 31 / 34 | 35 / 9 | 0M | 0M |
| Q3 2025 | 95 | 2M | 35.4% | 30 / 36 | 12 / 36 | 1M | 0M |
| Q2 2025 | 102 | 2M | 25.5% | 62 / 17 | 18 / 6 | 1M | 0M |
| Q1 2025 | 46 | 1M | 14.8% | 9 / 16 | 13 / 4 | 0M | 0M |
| Q4 2024 | 41 | 1M | 13.2% | 16 / 10 | 8 / 5 | 0M | 0M |
| Q3 2024 | 30 | 0M | 6.8% | 29 / 0 | 1 / 2 | 0M | 0M |
| Q2 2024 | 3 | 0M | 0.0% | 3 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
155 funds held NUTX in Q2 2026, 56% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NUTX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Avantis U.S. Small Cap Value ETF | 185,385 | 2.71% | $23.94M | 0.09% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 153,182 | 2.24% | $26.18M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 131,382 | 1.92% | $22.45M | 0.03% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 57,700 | 0.84% | $9.86M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 54,851 | 0.80% | $8.09M | 0.02% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 47,087 | 0.69% | $8.05M | 0.05% | Jun 30, 2026 |
| Pacer US Small Cap Cash Cows 100 ETF | 44,170 | 0.65% | $6.51M | 0.18% | Jul 31, 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 31,924 | 0.47% | $5.46M | 0.23% | Jun 30, 2026 |
| VictoryShares Small Cap Free Cash Flow ETF | 28,667 | 0.42% | $4.90M | 0.81% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 26,802 | 0.39% | $3.46M | 0.01% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 26,409 | 0.39% | $3.41M | 0.02% | May 31, 2026 |
| iShares Micro-Cap ETF | 16,858 | 0.25% | $2.88M | 0.19% | Jun 30, 2026 |
| First Trust Dow Jones Select MicroCap Index Fund | 16,671 | 0.24% | $2.85M | 1.07% | Jun 30, 2026 |
| Omni Small-Cap Value Fund | 15,000 | 0.22% | $2.56M | 0.19% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Health Care Services ETF | 13,849 | 0.20% | $2.37M | 1.69% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Thomas T. Vo | Chief Executive Officer, Director | 28,809,974 | 420.71% | May 29, 2026 |
| Warren Hosseinion | President, Director | 61,739 | 0.90% | Mar 23, 2026 |
| Wesley Shane Bamburg | Chief Operating Officer | – | – | Mar 24, 2026 |
| Pamela W. Montgomery | Chief Legal Officer-Healthcare | 2,758 | 0.04% | Mar 16, 2026 |
| Michael L. Chang | Chief Medical Officer | 82,356 | 1.20% | Mar 11, 2026 |
| Elisa V. Luqman | Chief Legal Officer - SEC | 4,224 | 0.06% | Mar 11, 2026 |
| Jon Christian Bates | Chief Financial Officer | 8,305 | 0.12% | Mar 11, 2026 |
| Joshua DeTillio | Chief Operating Officer | 6,481 | 0.09% | Apr 14, 2025 |
| Scott J. Saunders | Director | 400 | 0.01% | Sep 18, 2026 |
| Cheryl Yvonne Grenas | Director | 10,670 | 0.16% | Aug 3, 2026 |
| Frank E. Jaumot | Director | 753 | 0.01% | Aug 3, 2026 |
| Michael Lee Reed | Director | 670 | 0.01% | Aug 3, 2026 |
| Kelvin Spears | Director | 34,656 | 0.51% | Jun 4, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Scott J. Saunders Director | Sep 18, 2026 | Sale | −203 | $214.25 | $43.49K | 400 |
| Michael Lee Reed Director | Jul 31, 2026 | Option exercise | +603 | – | – | 670 |
| Scott J. Saunders Director | Jul 31, 2026 | Option exercise | +603 | – | – | 603 |
| Frank E. Jaumot Director | Jul 31, 2026 | Option exercise | +603 | – | – | 753 |
| Cheryl Yvonne Grenas Director | Jul 31, 2026 | Option exercise | +603 | – | – | 670 |
| Kelvin Spears Director | Jun 4, 2026 | Other | +2,519 | – | – | 34,656 |
| Thomas T. Vo Chief Executive Officer, Director | May 28, 2026 | Other | +75,747 | – | – | 2,103,014 |
| Thomas T. Vo Chief Executive Officer, Director | Apr 9, 2026 | Other | +184,071 | – | – | 2,027,267 |
| Frank E. Jaumot Director | Mar 20, 2026 | Buy | +150 | $93.56 | $14.03K | 150 |
| Warren Hosseinion President, Director | Mar 19, 2026 | Buy | +252 | $94.07 | $23.71K | 7,765 |
| Kelvin Spears Director | Mar 17, 2026 | Buy | +10 | $94.46 | $945 | 32,137 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Mar 13, 2026 | Buy | +79 | $88.87 | $7.02K | 2,758 |
| Thomas T. Vo Chief Executive Officer, Director | Mar 10, 2026 | Tax withholding | −3,017 | $86.22 | $260.13K | 1,843,196 |
| Thomas T. Vo Chief Executive Officer, Director | Mar 10, 2026 | Option exercise | +8,334 | – | – | 1,846,213 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Mar 10, 2026 | Option exercise | +2,084 | – | – | 3,455 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Mar 10, 2026 | Tax withholding | −776 | $86.22 | $66.91K | 2,679 |
| Michael L. Chang Chief Medical Officer | Mar 10, 2026 | Tax withholding | −769 | $86.22 | $66.30K | 82,356 |
| Michael L. Chang Chief Medical Officer | Mar 10, 2026 | Option exercise | +2,084 | – | – | 83,125 |
| Jon Christian Bates Chief Financial Officer | Mar 10, 2026 | Option exercise | +2,667 | – | – | 8,305 |
| Elisa V. Luqman Chief Legal Officer - SEC | Mar 10, 2026 | Option exercise | +2,084 | – | – | 3,154 |
| Elisa V. Luqman Chief Legal Officer - SEC | Mar 10, 2026 | Tax withholding | −784 | $86.22 | $67.60K | 2,370 |
| Warren Hosseinion President, Director | Mar 10, 2026 | Tax withholding | −3,274 | $86.22 | $282.28K | 7,513 |
| Warren Hosseinion President, Director | Mar 10, 2026 | Option exercise | +6,293 | – | – | 10,787 |
| Kelvin Spears Director | Mar 10, 2026 | Option exercise | +183 | – | – | 32,209 |
| Kelvin Spears Director | Mar 10, 2026 | Tax withholding | −82 | $86.22 | $7.07K | 32,127 |
| Jon Christian Bates Chief Financial Officer | Nov 25, 2025 | Buy | +750 | $136.71 | $102.53K | 5,638 |
| Jon Christian Bates Chief Financial Officer | Apr 8, 2025 | Buy | +1,000 | $81.81 | $81.81K | 4,888 |
| Michael L. Chang Chief Medical Officer | Apr 4, 2025 | Tax withholding | −266 | $72.10 | $19.18K | 81,041 |
| Kelvin Spears Director | Apr 4, 2025 | Tax withholding | −34 | $72.10 | $2.45K | 31,992 |
| Warren Hosseinion President, Director | Apr 4, 2025 | Tax withholding | −1,072 | $72.10 | $77.29K | 3,422 |
| Thomas T. Vo Chief Executive Officer, Director | Apr 4, 2025 | Tax withholding | +895 | $72.10 | $64.53K | 1,837,879 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Apr 4, 2025 | Tax withholding | −266 | $72.10 | $19.18K | 1,371 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Apr 4, 2025 | Tax withholding | −24 | $72.10 | $1.73K | 387 |
| Elisa V. Luqman Chief Legal Officer - SEC | Apr 4, 2025 | Tax withholding | −266 | $72.10 | $19.18K | 1,070 |
| Joshua DeTillio Chief Operating Officer | Apr 4, 2025 | Tax withholding | −452 | $72.10 | $32.59K | 6,481 |
| Michael L. Chang Chief Medical Officer | Mar 1, 2025 | Option exercise | +1,250 | – | – | 81,307 |
| Kelvin Spears Director | Mar 1, 2025 | Option exercise | +143 | – | – | 32,026 |
| Warren Hosseinion President, Director | Mar 1, 2025 | Option exercise | +3,776 | – | – | 4,494 |
| Thomas T. Vo Chief Executive Officer, Director | Mar 1, 2025 | Option exercise | +5,000 | – | – | 1,838,774 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Mar 1, 2025 | Option exercise | +1,250 | – | – | 1,637 |
| Pamela W. Montgomery Chief Legal Officer-Healthcare | Mar 1, 2025 | Option exercise | +111 | – | – | 411 |
| Jon Christian Bates Chief Financial Officer | Mar 1, 2025 | Option exercise | +111 | – | – | 2,388 |
| Jon Christian Bates Chief Financial Officer | Mar 1, 2025 | Option exercise | +1,500 | – | – | 3,888 |
| Elisa V. Luqman Chief Legal Officer - SEC | Mar 1, 2025 | Option exercise | +1,250 | – | – | 1,336 |
| Joshua DeTillio Chief Operating Officer | Mar 1, 2025 | Option exercise | +2,125 | – | – | 6,933 |
| Thomas T. Vo Chief Executive Officer, Director | Jan 8, 2025 | Gift | +5,000 | – | – | 1,833,774 |
| Jon Christian Bates Chief Financial Officer | Aug 22, 2024 | Buy | +1,350 | $21.46 | $28.97K | 2,277 |
| Joshua DeTillio Chief Operating Officer | Aug 20, 2024 | Buy | +575 | $17.40 | $10.01K | 4,808 |
| Joshua DeTillio Chief Operating Officer | Aug 19, 2024 | Buy | +1,300 | $17.85 | $23.21K | 4,233 |
| Thomas T. Vo Chief Executive Officer, Director | Jul 12, 2024 | Award | +22,709 | – | – | 1,828,774 |
| Joshua DeTillio Chief Operating Officer | Jun 12, 2024 | Buy | +20,000 | $0.54 | $10.80K | 29,333 |
| Thomas T. Vo Chief Executive Officer, Director | May 30, 2024 | Buy | +2,986 | $0.66 | $1.97K | 18,060,663 |
| Thomas T. Vo Chief Executive Officer, Director | May 29, 2024 | Buy | +3,768 | $0.68 | $2.56K | 18,057,677 |
| Thomas T. Vo Chief Executive Officer, Director | May 28, 2024 | Buy | +48,394 | $0.70 | $33.88K | 18,053,909 |
| Thomas T. Vo Chief Executive Officer, Director | May 13, 2024 | Buy | +17,330 | $0.69 | $11.96K | 18,005,515 |
| Pamela W. Montgomery Chief Legal Officer | Mar 12, 2024 | Option exercise | +16,502 | – | – | 45,004 |
| Jon Christian Bates Chief Financial Officer | Mar 12, 2024 | Option exercise | +49,505 | – | – | 139,010 |
| Thomas T. Vo Chief Executive Officer, Director | Nov 20, 2023 | Buy | +275,200 | $0.23 | $63.30K | 269,822,776 |
| Thomas T. Vo Chief Executive Officer, Director | Nov 17, 2023 | Buy | +224,800 | $0.23 | $51.70K | 269,547,576 |
| Joshua DeTillio Chief Operating Officer | Nov 15, 2023 | Buy | +140,000 | $0.24 | $33.60K | 140,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
17.01%
1M shares short
Days to cover
10.1
At 0M shares a day
Change since last report
-5.9%
From 1M shares
Short volume, 20 days
64.0%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Nutex Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,616 shares on Aug 20, 2026 over the last 90 days.
See a number that looks wrong?